doi: 10.3389/fimmu.2026.1755316 Received 27 November 2025 Revised 11 July 2026 Accepted 22 July 2026 Published 03 August 2026 Volume 17 - 2026 Edited by Manuel Muro, Virgen de la Arrixaca University Hospital, Spain Reviewed by Paola Pontrelli, University of Bari Aldo Moro, Italy Benjamin Spector, University of Wisconsin-Madison, United States Updates Copyright 2026 Zhang, Zheng, Zheng, He, Chen, Luo, Wang and Cai
Follow the 20-20-20 rule for screens: every 20 minutes, look 20 feet away for 20 seconds, and blink fully
India has the worlds second-largest population of type-2 diabetes patients. Obesity rates are also a growing concern in India, and, as in the United States, Ozempic may be used to treat diabetes or be prescribed off-label for weight loss purposes in India
While compounded semaglutide may seem like a more affordable alternative, it carries significant risks due to the lack of oversight, making FDA-approved options like Ozempic, Wegovy, and Mounjaro the safer, more reliable choices for weight loss